Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2008 May;393(3):423-5.
doi: 10.1007/s00423-007-0217-y. Epub 2007 Aug 17.

Uneventful splenectomy and cholecystectomy in a patient treated with anti-interleukin-6 receptor antibody therapy

Affiliations
Case Reports

Uneventful splenectomy and cholecystectomy in a patient treated with anti-interleukin-6 receptor antibody therapy

Morihiko Ishizaki et al. Langenbecks Arch Surg. 2008 May.

Abstract

Introduction: Interleukin-6 (IL-6) is a multifunctional cytokine that regulates various aspects of the immune responses, acute phase reactions, and hematopoiesis. In rodent models, IL-6 has been suggested to be one of the essential mediators for optimal acute phase responses to infection and tissue damage. However, in humans, the roles of IL-6 in acute phase responses after surgery remain poorly understood.

Case report: We present the first case report of successful splenectomy and cholecystectomy in a severe autoimmune-associated hemolytic anemia patient during treatment with a humanized anti-IL-6 receptor antibody.

Discussion: This unique case suggests that IL-6 is not an essential cytokine to safely perform surgical intervention and to prevent postoperative complications and that surgical intervention may not be contraindicated but can be selected as a therapeutic modality in patients treated with anti-IL-6 receptor antibody therapy.

PubMed Disclaimer

Similar articles

References

    1. Arthritis Rheum. 2004 Jun;50(6):1761-9 - PubMed
    1. Nat Clin Pract Rheumatol. 2006 Nov;2(11):619-26 - PubMed
    1. Blood. 2005 Oct 15;106(8):2627-32 - PubMed
    1. Nature. 1994 Mar 24;368(6469):339-42 - PubMed
    1. Int J Hematol. 2004 Oct;80(3):246-9 - PubMed

Publication types

LinkOut - more resources